Catalog Number | : | CS-EK-01503 |
---|---|---|
CAS Number | : | 153559-49-0 unlabeled |
Status | : | Available |
List Price | Online Price | Size | Stock Status | Quantity | |
---|---|---|---|---|---|
![]() |
Chemical Name | : | [13C6]-Bexarotene |
---|---|---|
Category | : | Isotope Labelled Compounds |
Status: | : | Available |
---|---|---|
COA | : |
[Login Needed]
|
MSDS | : |
[Login Needed]
|
Payment mode | : | Credit / Debit / Purchase Order |
---|---|---|
Taxes | : | All prices are inclusive taxes |
Refund Policy | : | 30 days money back guarantee |
Canonical SMILES | : | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
---|---|---|
Isomeric SMILES | : | CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C |
InChI | : | InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26) |
InchIKey | : | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
IUPAC Name | : | 4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid |
Exact Mass | : | 348.208930132 |
Color | : | Off-white to white powder |
Melting Point | : | 230-231 °C |
Solubility | : | Insoluble in water and slightly soluble in vegetable oils and ethanol |
Use Classification | : | Human drugs -> Targretin -> EMA Drug Category |
Hazard Class | : | Acute Tox. 4 (12.5%) |
Description | : | Bexarotene is a retinoid, a member of benzoic acids and a member of naphthalenes. It has a role as an antineoplastic agent. |
Disposal Methods | : | /PRECAUTIONS FOR ANTINEOPLASTIC AGENTS:/ All contaminated disposables should be contained in sealable bags for transfer to larger waste containers. /Antineoplastic agents/ |
EC Number | : | 681-650-8 |
Vapor Pressure | : | 3.5X10-9 mm Hg at 25 °C (est) |
Antidoteand Emergency Treatment | : | Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for pulmonary edema and treat if necessary ... . Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Cover skin burns with dry sterile dressings after decontamination ... . /Poisons A and B/ |
Human Toxicity Excerpts | : | /HUMAN EXPOSURE STUDIES/ Doses up to 1000 mg/sq m /day of /bexarotene/ capsules have been administered in short-term studies in patients with advanced cancer without acute toxic effects. |